Silver Book reference

Incentives for R&D for New Antimicrobial Drugs: Research paper 11/02

1 Matching Fact

Search matching Facts:
No results to display
    • Negative value of antibiotics to drug companies
      The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.